AN2 Therapeutics Inc
ANTXLatest QuantConomy context for ANTX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
AN2 Therapeutics Inc
QuantConomy has a structured record for ANTX. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- ANTX
- Name
- AN2 Therapeutics Inc
- Coverage
- 3 market/data records
- Sources
- fmp alphavantage alpaca sec nasdaq
Recent signals for ANTX
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| earnings release | neutral | 40 | Mar 17, 12:00 AM | ANTX filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-03-17. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| earnings release | neutral | 40 | May 11, 12:00 AM | ANTX filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-05-11. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| other event | neutral | 35 | Jun 9, 10:05 AM | ANTX filed 8-K: Shareholder Vote Results - [weak neutral signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| ANTX | NASDAQ | fmp | AN2 Therapeutics, Inc. |
| ANTX | NASDAQ | alphavantage | AN2 Therapeutics Inc |
| ANTX | NASDAQ | alpaca | AN2 Therapeutics, Inc. Common Stock |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Marks Gilbert Lynn | Director | grant | 2,789 | $0.00 | $0 | 4 on EDGAR |
| Jul 10, 2026 | Aziz Kabeer | Director | grant | 2,852 | $0.00 | $0 | 4 on EDGAR |
| Jul 10, 2026 | Martin Patricia A. | Director | grant | 766 | $0.00 | $0 | 4 on EDGAR |
| Jul 8, 2026 | Eizen Joshua M | See Remarks | sale | 5,945 | $4.17 | $24,803 | 4 on EDGAR |
| May 29, 2026 | Williams Sarah Joanne | Principal Accounting Officer | sale | 265 | $4.43 | $1,174 | 4 on EDGAR |
| Apr 10, 2026 | Martin Patricia A. | Director | grant | 1,192 | $0.00 | $0 | 4 on EDGAR |
| Apr 10, 2026 | Marks Gilbert Lynn | Director | grant | 3,775 | $0.00 | $0 | 4 on EDGAR |
| Apr 10, 2026 | Aziz Kabeer | Director | grant | 3,775 | $0.00 | $0 | 4 on EDGAR |
| Mar 19, 2026 | Day Lucy | Chief Financial Officer | grant | 73,665 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Chanda Sanjay | Chief Development Officer | grant | 66,000 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Readnour Robin Shane | Director | grant | 20,724 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Eizen Joshua M | See Remarks | grant | 92,000 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Martin Patricia A. | Director | grant | 24,999 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Aziz Kabeer | Director | grant | 20,724 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Marks Gilbert Lynn | Director | grant | 10,665 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Zakrzewski Joseph S | Director | grant | 99,999 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Easom Eric | Chief Executive Officer | grant | 249,999 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Wong Stephanie | Director | grant | 24,999 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Spigelman Melvin K | Director | grant | 16,941 | — | — | 4 on EDGAR |
| Mar 19, 2026 | FitzPatrick Margaret M | Director | grant | 11,463 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query ANTX context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access